Photon

Photon Biosciences is developing a next-generation diagnostics platform (PBSDx) that integrates bioengineered luminescent bionanoparticles, optical imaging, and artificial intelligence for ultrasensitive, portable, and rapid diagnostic testing in human and veterinary health. Their lead programs focus on detecting microbial contamination in donated platelets (to prevent transfusion-related sepsis) and multiplexed, point-of-solution heart failure diagnostics. The platform technology is non-bleaching, non-blinking, and tunable across visible and near-infrared wavelengths, offering potential advantages over traditional fluorescent probes for research and clinical applications.